The Bone Morphogenetic Proteins (BMPs) are required for the development of ventral mesoderm, which contributes to the ventral blood island and primitive (yolk sac stage) hematopoiesis. Primitive erythropoiesis is defective when BMP signaling is blocked during gastrulation of Xenopus embryos. This phenotype might be attributed to changes in mesoderm patterning leading indirectly to altered erythropoiesis. We developed an inducible system in order to block BMP signaling in a controlled fashion at later time points in development. For this purpose, an inhibitory Smad, xSmad6, was fused to the estrogen receptor ligand binding domain.
patterning leading indirectly to altered erythropoiesis. We developed an inducible system in order to block BMP signaling in a controlled fashion at later time points in development. For this purpose, an inhibitory Smad, xSmad6, was fused to the estrogen receptor ligand binding domain.
We show that ER-xSmad6 is inactive when expressed in developing embryos, but its activity is induced by estradiol. When induced early in development, ER-xSmad6 causes a dorsalized phenotype, equivalent to over-expression of native xSmad6. When ER-xSmad6 is induced after gastrulation, there is a specific defect in primitive erythropoiesis without any apparent effect on axial patterning. Our results identify an embryonic signal that is Smad-dependent, is required for maintaining expression of GATA-1, and functions within mesoderm and not the overlying ectoderm. Thus, BMP signaling is necessary both during mesoderm patterning and also following early specification events for proper regulation of the primitive erythroid lineage.
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INTRODUCTION
The first blood cells develop during embryogenesis on the extra-embryonic yolk sac of birds and mammals, and at analogous sites within the ventral blood island (VBI) of Xenopus, or the ventral intermediate cell mass (ICM) associated with the tail in bony fish. This hematopoiesis is referred to as embryonic or primitive, in order to distinguish it from the subsequent intraembryonic derived definitive lineage that sustains hematopoiesis throughout later life. Primitive hematopoiesis is devoted largely to erythropoiesis; the primitive erythroid cells have a morphology, gene expression program, and life-span that is distinct from fetal liver or bonemarrow derived definitive erythroid cells. The signaling molecules that regulate primitive hematopoiesis are not known and at least some of the regulatory factors that are required for definitive erythropoiesis are not be essential, including c-myb, and runx1 [1] [2] [3] [4] [5] . Studies using embryonic stem (ES) cells 6, 7 and novel transplantation protocols [8] [9] [10] indicate that primitive progenitors have an inherent potential to contribute to definitive hematopoiesis. The unique birthplace of primitive progenitor cells must therefore provide a stromal environment conducive for primitive hematopoiesis.
In Xenopus the first erythrocytes differentiate within the VBI about 2 days after fertilization. Recent fate-mapping studies established that blastomeres with presumptive dorsal or ventral fates both contribute to primitive hematopoiesis [11] [12] [13] , but all primitive erythroid cells eventually differentiate in the VBI, the most ventral embryonic structure. It is well established that members of the Bone Morphogenetic Protein (BMP) sub-family of TGF-growth factors are required during gastrulation for specifying the ventral character of embryonic mesoderm and are therefore candidates for controlling the development of VBI-derived blood progenitors.
For personal use only. on . by guest www.bloodjournal.org From Indeed, a role for BMPs in regulating hematopoiesis is supported by several lines of investigation. First, the components of BMP signaling (ligands, receptors, and the Smad proteins that mediate signaling) are present and active at the right time and place to regulate the primitive hematopoietic lineage. Second, ectopic BMP signaling activates the primitive erythroid program, while inhibiting the pathway blocks VBI development 14, 15 . Hedgehog proteins, probably mediated by BMP2 and/or BMP4, are sufficient to reprogram anterior ectoderm and induce primitive erythropoiesis in murine embryonic explants 16 . Third, mouse embryos that survive an early embryonic lethality of the targeted BMP4 mutation have severely reduced primitive blood islands 17 , and fish embryos mutant for BMP2 or BMP7 lack blood entirely 18 . Finally, BMP4 can regulate in vitro hematopoietic development of mouse 19, 20 or monkey 21 embryonic stem cells, myeloma cells 22 , and purified repopulating progenitors 23, 24 .
Therefore, in addition to their role in patterning the ventral mesoderm, BMPs may act directly on hematopoietic progenitors or stromal elements, in synergy with other embryonic signaling proteins 19, [25] [26] . However, defining precisely the mechanism by which BMPs influence hematopoiesis has been a challenge. The genetic analyses (mutants and knockouts) are complicated by very early and pleiotropic embryonic requirements for BMP signaling and presumed functional redundancies 27, 28 . The direct targets of BMP signaling include a class of homeobox containing genes (Vents) that specify ventral mesoderm, but there is no evidence that these factors regulate later stages of hematopoiesis [29] [30] [31] . However, direct or indirect BMP target genes also include transcription factors that are critical for hematopoiesis. Expression of GATA-1, GATA-2, LMO-2, SCL and EKLF are activated by BMP-signaling 15, [32] [33] [34] . In order to study the function of BMP signaling beyond stages of ventral specification, it is necessary to For personal use only. on September 14, 2017. by guest www.bloodjournal.org From bypass the early requirement and provide a conditional block to signaling after specification has occurred. We devised a strategy to accomplish this goal and we demonstrate the specific requirement of a Smad-dependent signaling pathway for efficient primitive erythroid cell differentiation, independent of any early requirement for cell specification. Our results suggest that GATA-1 is dependent on this signal within the specified mesoderm, and that in its absence decreased levels of GATA-1 correlate with defects in primitive erythroid cell differentiation.
MATERIALS AND METHODS

Plasmid Construction
The pCS2-ER-xSmad6 expression plasmid was constructed by first ligating an approximately 1.0 kb EcoRI/BamHI PCR fragment generated from pCS2-xSmad6 (a gift from J.
Christian) into pBluescript II KS (+/-) to create pKS-xSmad6. The PCR fragment was generated using forward primer (TE647): ATAGAATTCACCATGTTCAGGTCCAGACGC and reverse primer (TE648): ATAGGATCCCCTCTTCCCAGTAGGACCTC. A 945 bp ClaI/EcoRI PCR fragment containing the human estrogen receptor ligand binding domain was generated from pBabepuroNmyc-ER (a gift from A. Iavarone) using forward primer (TE703):
ATAATCGATACCATGTCTGCTGGAGACATGAGA and reverse primer (TE704):
ATAGAATTCCCCGACTGTGGCAGGGAAACC. This ClaI/EcoRI fragment was ligated into pKS-xSmad6 to create pKS-ER-xSmad6. A ClaI/BstEII fragment from pKS-ER-xSmad6 was then ligated back into pCS2-xSmad6 to generate pCS2ER-xSmad6, which was used to generate mRNA for injection. The pEGFP-ER-xSmad6 expression plasmid was constructed by ligating a BamHI/KpnI fragment from pKS-ER-xSmad6 containing ER-xSmad6 into pEGFP-C1 SDS-PAGE gels followed by electroblotting to PVDF filters (Biorad). Blots were incubated in primary antibody (anti-hER (578-595) polyclonal antibody (Sigma) 1:2000 in PBST) for one hour at room temperature, and secondary antibody (anti-rabbit-HRP (Biorad) 1:8000 in PBST)
for one hour at room temperature. Signal was detected using the ECL+Plus detection system (Amersham).
Northern Blot Analysis
Total RNA was isolated from 10 -15 uninjected stage 35 embryos or ER-xSmad6 mRNA injected embryos cultured in the presence or absence of 1 µM E2 using TRI REAGENT® (Molecular Research Center). For polyA+ blots, approximately 100 embryos per condition were homogenized. Embryos were homogenized in 1.5 mL microfuge tubes using Kontes pestles.
PolyA+ mRNA was harvested from total RNA using PolyATract® mRNA Isolation System (Promega). 10 µg of total RNA or 0.8 µg of polyA+ mRNA was size fractionated on a 1% agarose gel in 3% formaldehyde, MOPS buffer. Fractionated RNA was transferred to a Nylon filter (Ambion) in 10X SSC. A 600 bp HindIII/XhoI fragment of T 1 -globin, 1.9 kb EcoRI fragment of xGATA-1A, 1.3 kb EcoRI fragment of xGATA-2, 1.9 kb EcoRI fragment of xSCL, 2.0 kb EcoRI/NotI fragment of neptune, or a 1.7 kb EcoRI fragment of EF-1 was radiolabeled
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Luciferase Reporter Assay
Two to four cell Xenopus embryos were injected with combinations of pBRE-Luc (25 pg per blastomere), p3TP-Lux (25 pg per blastomere), Renilla mRNA (0.1 pg per blastomere), xBMP4 mRNA (62.5 pg per blastomere), activin B mRNA (100 pg per blastomere), xSmad6 mRNA (500 pg per blastomere), BR mRNA (500 pg per blastomere), ER-xSmad6 mRNA (500 pg per blastomere) or EF-1 mRNA (500-600 pg per blastomere) as a control to maintain constant amounts of injected mRNA. Injected embryos were cultured until stage 13/14, when they were harvested in 1X Passive Lysis Buffer (Promega). Extracts were tested using the Dual Luciferase Reporter Assay Kit (Promega). Four to six samples were tested for each condition and the assays were performed in triplicate. Luciferase values were averaged and normalized over the average Renilla value.
RESULTS
ER-xSmad6 facilitates a conditional block to BMP-regulated Smad signaling during embryogenesis.
BMP signaling is regulated at many levels, but key components are serine/threonine receptor complexes and Smad transcriptional co-factors that transmit the signal from the receptor to the nucleus [37] [38] [39] [40] . Four sub-classes of Smads are known: Receptor mediated (R-Smad) 2 and 3
control TGF-/activin signaling, R-Smads 1, 5, and 8 are activated by BMPs, Smad4 is the co- [45] [46] [47] . To avoid disrupting mesoderm specification, other approaches have been used, including delayed expression of the dominant negative receptor using a plasmid promoter 15 or titration of the truncated receptor 26 . Although the results suggest a hematopoietic role for BMP signaling beyond mesoderm specification, these approaches can not definitively rule out primary defects in ventral cell-type specification during gastrulation that lead indirectly to the changes seen in hematopoiesis. While still relevant to understanding progenitor cell specification, these approaches are less useful for analyzing signals that act subsequently on the progenitors.
To address this issue, we exploited the natural activity of negative-acting I-Smads to develop an approach for blocking conditionally BMP-dependent Smad signaling. Because xSmad6 is thought to be specific to the BMP pathway, we focused on this gene product. The cDNA encoding xSmad6 was fused to the ligand-binding domain of the human estrogen receptor. We considered that the fusion protein might be sequestered in an inactive state, which would be released upon estrogen induction to function either at the receptor or in the nucleus to block BMP signaling (Fig. 1) .
Fig. 1
Fusion of ER sequences at the C-terminus inhibited xSmad6 function (not shown). In contrast, the N-terminal ER-xSmad6 fusion protein blocks BMP-regulated Smad signaling, but only in the presence of estrogen (E2). Uninjected embryos cultured alone ( Fig. 2A ) or in the presence of E2 (Fig. 2B ) appear entirely normal. As shown in Fig. 2C , injection of mRNA encoding ER-xSmad6 into fertilized eggs has no effect on development when the embryos are raised in normal medium. However, when injected embryos are cultured in the presence of 1 µM E2, they develop severely dorsalized with a high percentage of twinned dorsal axes (Fig. 2D ).
This phenotype is identical to that of embryos injected with the full-length wild-type xSmad6 mRNA ( Fig 2E) . Therefore, ER-xSmad6 can be activated conditionally by the addition of E2 and functions like the native protein to block ventral mesoderm development.
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Fig. 2
The mechanism by which xSmad6 blocks BMP signaling is not entirely clear but is thought to occur by interfering competitively with R-Smad access to either receptors or Smad4.
Alternatively it is possible that Smad6 interferes in some manner with the nuclear function of RSmad/Smad4 complexes. The traditional use of ER-fusions has been to sequester nuclear transcription factors to the cytoplasm until E2 facilitates release of the protein to act in the nucleus [48] [49] [50] [51] . Therefore, it was of interest to determine the site of action for the E2-activated ERxSmad6 fusion protein. For this purpose, the ER-xSmad6 cDNA was fused to the C-terminus of GFP to create a GFP-ER-xSmad6 protein. When expressed in HepG2 cells by transient transfection, GFP-ER-xSmad6 is located diffusely throughout the cytoplasm and excluded from the nucleus (Fig. 3A) . Within 30 min of addition of E2 to the medium, the fusion protein begins to localize to restricted cytoplasmic punctate speckles in many cells (not shown). By 90 min after addition of E2, all cells show this cytoplasmic speckling (Fig. 3C) . Therefore, consistent
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From with some previous analyses of xSmad6 localization 44 , the activated ER-xSmad6 fusion protein appears to localize to the plasma membrane, presumably acting at receptor complexes to block signaling. When EGFP plasmid alone was injected into Xenopus embryos and cultured in the absence (Fig. 3E) or presence (Fig. 3F ) of E2, there was no change in localization. When the GFP-ER-xSmad6 fusion protein is expressed in embryos, it dorsalizes embryos conditional to the presence of E2 (not shown), and is localized similarly to speckled cytoplasmic sites (Fig. 3H) . It is thought that xSmad6 mainly inhibits BMP signaling 42 , although inhibition of activin/TGF-signaling has not been ruled out entirely. Because activin/TGF-signaling may also play roles in hematopoietic development 19, 25, 52 , and to be certain that the addition of ER sequences to Smad6 did not alter its function, we investigated further the specificity of ERxSmad6. We conducted luciferase reporter assays using a multimerized BMP response element from the xVent2 promoter (BRE-luc) 53 or the TGF-responsive reporter, p3TP-Lux 54 . These reporters serve to assay active signaling by Smads 1/5/8 or Smads 2/3, respectively. Either xSmad6 or the dominant negative BMP Type I receptor BR strongly inhibits BMP4-mediated activation of the BRE-luc reporter, whereas neither of these proteins inhibits activin-mediated activation of the p3TP-Lux reporter (Fig. 4A ). ER-xSmad6 was similarly unable to reduce activin-mediated p3TP-Lux activation (Fig. 4B) . In comparison, ectopic expression of ERxSmad6, in the absence of E2, inhibits BMP mediated activation of the reporter approximately 50% (Fig. 4C) . In this assay the ER-xSmad6 protein is therefore slightly "leaky". However, this activity may not be physiologically relevant, since these embryos develop normally. In the presence of E2, ER-xSmad6 completely eliminates BMP reporter activity. Therefore, ERxSmad6 is as effective at blocking BMP signaling as native xSmad6 and does not inhibit activin/TGF-signaling. ER-xSmad6 can be used to evaluate post-specification requirements of BMP signaling.
The stability of ectopic ER-xSmad6 was evaluated by western blotting experiments. The protein derived from mRNA injected into fertilized eggs is stable through gastrula and neurula stages, but eventually declines by around stage 23 of tailbud tadpoles (Fig. 5A) . However, induction of the fusion protein with E2 did not provoke significant morphological defects as long as the E2 was added to the medium at or after stage 10.5 (mid-gastrulation). Beyond this point,
80-95% of the embryos developed with a normal body axis, compared to only 25% of the embryos induced with E2 between stages 7-9 (Fig. 5B ). This provides a window of development (stages [13] [14] [15] to test the effect of blocking BMP signaling between the end of gastrulation and tailbud stages.
Fig. 5
As an initial test for alterations in blood island development, embryos were injected into both ventral blastomeres at the 4-cell stage with the ER-xSmad6 mRNA, and cultured in normal medium, or medium that was supplemented with E2 at stage 13. All embryos were fixed at stage 35/36 and analyzed for normal blood island development by assaying reactivity with benzidine, which stains hemoglobin. Mock-injected embryos cultured without (Fig. 6A ) or with addition of E2 (Fig. 6B) showed normal patterns of benzidine staining. As shown in Fig. 6C 
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embryos cultured in the absence of E2 show no reduction of blood island development, whereas activation of ER-xSmad6 after gastrulation (Stage 13) results in defects of primitive erythropoiesis, illustrated by significantly decreased VBI staining (Fig. 6D) . The embryos induced at stage 13 appear otherwise entirely normal, with a complete dorsal-ventral axis and no evidence of dorsalized structures. Injection of the ER ligand binding domain alone had no effect on the gross morphology or VBI development of the embryos (not shown). This result demonstrates a Smad6-sensitive signaling pathway required after gastrulation stages for normal VBI development.
Fig. 6
Late induction of ER-xSmad6 decreases expression levels for globin and GATA-1.
The defect in benzidine staining could be due to a block in erythropoiesis at any of several levels. To determine if the defect is related to the erythroid transcriptional program, embryos expressing ER-xSmad6 were incubated with E2 starting at various stages; RNA was
harvested from all the embryos at stage 35/36 and analyzed by northern blotting experiments for globin transcripts. As shown in Fig. 6E , activation of ER-Smad6 prior to gastrulation (stage 7) or during gastrulation (stage 10.5) nearly eliminates globin mRNA, compared to embryos that were not exposed to E2. The results at these stages are consistent with the failure to specify hematopoietic mesoderm. However, when exposure to E2 was delayed until stage 15 (neurulation), the resulting embryos still show a significant relative decrease in globin transcript levels. If E2 is not added until stage 23, the embryos express normal levels of globin RNA, but this may simply reflect the fact that ER-xSmad6 protein levels decline by this stage (see Fig.   5A ). Levels of globin transcript in the injected, untreated controls (NH) are equivalent to noninjected embryos (not shown).
To determine if this defect in erythropoiesis acts at the level of regulatory genes, the transcript levels for known hematopoietic transcription factors were analyzed quantitatively in polyA+ northern blotting experiments. Embryos were treated with E2 at stage 7 or 13 and harvested at either stage 22 or stage 35/36 to analyze early or late markers of primitive hematopoiesis, respectively. As expected, transcript levels for GATA-2 and SCL are decreased when embryos are dorsalized by induction of ER-xSmad6 at stage 7 (Fig. 7A) . Interestingly, when injected embryos were induced at the onset of neurulation (stage 13), transcript levels of GATA-2 and SCL at stage 22 are equivalent to untreated controls. This suggests that these early specification genes (which are expressed already during gastrula stages) do not require subsequent BMP signals to maintain steady state transcript levels at least up to stage 22.
Transcript levels for globin, neptune, and GATA-1 were also reduced in the stage 7 induced embryos (Fig. 7B) , as expected. When embryos were treated with E2 at stage 13, GATA-1, For personal use only. on September 14, 2017. by guest www.bloodjournal.org From levels were too low to assess quantitatively at stage 22, but RT-PCR analysis indicated that, similar to GATA-2 and SCL, these were normal during those early stages of VBI development, as long as E2 addition was delayed to stage 13 (not shown). These data suggest that BMP signaling continues to function at relatively late stages of blood island development for efficient differentiation of the primitive erythroid lineage. Recent studies revealed that the VBI is composed of distinct anterior and posterior domains that are derived from early dorsal or ventral fated blastomeres 13 . To determine if the anterior VBI is dependent on BMP signaling, embryos were injected at the four cell stage into
For personal use only. on September 14, 2017. by guest www.bloodjournal.org From the two prospective dorsal blastomeres, and induced with E2 at stage 10.5. Similar experiments using BR had shown that this has no effect on dorsal/ventral patterning 55 , and indeed no morphological defects occurred. However, benzidine staining shows that the anterior VBI fails to differentiate primitive erythroid cells (Fig. 8A, 8C and Table 1 ). We next tested if targeting ERxSmad6 RNA to the two ventral-fated blastomeres at the four cell stage would be sufficient to inhibit VBI development in the posterior compartment. Embryos treated with E2 at stage 10.5
did have a significant block to erythropoiesis, determined by staining for hemoglobin with benzidine. This block was restricted to the posterior VBI (Fig. 8B, 8D and Table 1 ), and the embryos retained a small segment of differentiated anterior blood island. Therefore, the entire blood island is dependent on BMP signaling for erythroid differentiation, regardless of the embryonic origin of the progenitors. Over-expression of xSmad1, but not xSmad2, rescues the ER-xSmad6 phenotype.
BMP signaling is mediated by three receptor activated Smads, (1/5/8), whereas activin/TGF-signaling is mediated by Smads 2/3. To confirm that ER-xSmad6 interferes with blood development by antagonizing BMP dependent Smads, rescue experiments were performed using specific R-Smads (Fig. 9) . When control xEF-1 mRNA was co-injected with ER-xSmad6 mRNA into the ventral blastomeres of four cell embryos, the embryos had absent or reduced posterior blood islands after addition of E2 at St. 10.5, whereas the injected, untreated embryos had normal (anterior and posterior) ventral blood islands (Fig 9A, D) . When xSmad1 mRNA was co-injected with ER-xSmad6 mRNA, the induced embryos developed normal VBIs (Fig. 9E ).
When xSmad2 mRNA was co-injected with ER-xSmad6 mRNA, the untreated embryos developed only anterior blood islands (indicating that Smad2 inhibits VBI development) and the E2-induced embryos were either fully dorsalized or developed only anterior blood islands (Fig.   9C, F) . These data support the conclusion that ER-xSmad6 is a specific inhibitor of BMPdependent Smad signaling and indicate that the post-mesoderm specification requirement for BMP signaling in the primitive hematopoietic compartment is Smad-dependent. Previous studies suggested that ectoderm overlying ventral mesoderm (VM) during gastrulation provides a stimulatory factor required for erythropoiesis 56 . In explant assays, stage 10 ventral mesoderm cultured alone fails to develop erythroid cells, while globin expression is induced if the explant is co-cultured with stage 10 (but not stage 7) animal cap (AC) presumptive ectoderm 59, 60 . BMP4 is expressed in both the mesoderm and ectoderm, and forced expression of BMP4 confers the ability of stage 7 AC ectoderm to induce globin in VM explants 33 . By attempting to target the dominant negative BMP receptor to these tissues, evidence was presented that BMP signaling in ectoderm is required for erythroid differentiation in the adjacent mesoderm 61 . Using ER-xSmad6, we are now able to investigate the temporal requirement of Smad-signaling in defined embryonic tissues. For this purpose, VM and AC explants were isolated from embryos derived from ER-xSmad6 injected or uninjected eggs (Fig. 10) . When uninjected AC and VM explants are co-cultured in the presence of E2 from the equivalent of stage 13, globin is readily induced. If AC and VM explants both pre-loaded with ER-xSmad6 are co-cultured in the presence of E2 from stage 13, globin expression is blocked. In other samples, equivalent cultures were prepared using explant pieces that differentially express ER-xSmad6. BMP signaling is implicated in regulating primitive erythropoiesis based on the ability of BMP4 to induce the erythroid program in uncommitted AC cells that serve as a model stem cell system in Xenopus 15, 33 . Similar ectopic expression studies show that a conserved pathway functions in murine ES cells 19, 32 . This is supported by genetic studies since BMP-4 -/-embryos that survive long enough to be analyzed lack yolk sac blood islands 17 . Zebrafish mutants defective in BMP signaling components also lack primitive blood 57 . However, it has been less clear if BMP function is restricted to the early specification of hematopoietic progenitors, since the approaches used (null mutations or forced expression of dominant negative receptors) inherently lead to mesoderm patterning defects that preclude a clear examination of BMP signaling at later developmental stages.
In order to address the question of whether BMP-dependent Smad signaling is required after hematopoietic progenitors are specified, we generated ER-xSmad6, a cell-autonomous inducible inhibitor of BMP-regulated Smads. Induction of this protein during neurulation, after the erythroid regulatory program has already been initiated in the presumptive VBI, is sufficient to cause quantitative defects in primitive erythropoiesis. Morphological analysis showed that induction of ER-xSmad6 before gastrulation causes a dorsalized phenotype, consistent with the phenotype of embryos where BMP signaling is blocked in a non-conditional manner 45, 47, 55, 58 .
BMP signaling at this time is required for specification of the embryonic hematopoietic In contrast, induction of ER-xSmad6 at the onset (stage 13) or during neurulation does not affect morphological development of the embryos, yet causes a reduction in primitive erythropoiesis. We showed that this inhibitor blocks a BMP regulated Smad-dependent pathway since xSmad1 rescues the defect, while xSmad2 does not. BMP signaling remains active in the presumptive ventral blood island during neurula stages at least up to stage 20, demonstrated by immunostaining for activated xSmad1 64 . The erythroid regulatory program is initiated by stage 11, based on the expression of critical regulatory transcription factors including GATA-2, LMO-2, SCL, and GATA-1 34, 62, 65, 66 . The approach of using an inducible inhibitor permits the normal specification of progenitors to occur during gastrulation and demonstrates that continued BMP signaling is required for efficient primitive erythropoiesis. When ER-xSmad6 is activated during these later stages (stage 13), the expression levels of GATA-2 and SCL are not reduced during VBI development. This indicates that the initial induction events were sufficient to activate these genes associated with early progenitor state, and BMP signaling is no longer required after gastrulation for their maintenance. However, the eventual reduction in globin, neptune, and GATA-1 transcript levels demonstrate that continued BMP signaling is still required for the efficient differentiation of primitive erythroid cells in the VBI. Our explant assays support the 
